The Smart Capsule Study

The study drug will be administered using RaniPill™ capsule, which delivers medications orally rather than via subcutaneous injection. Once the capsule is swallowed, it travels through to the first part of the gut, the coating of the capsule dissolves and a very small needle (size of uncooked rice) is pressed against the gut to slightly penetrate its wall and leave behind a tiny amount of medication compressed in a tablet. After this the needle dissolved and the remnants of the RaniPill™ are then carried with liquids and food down the intestine and excreted.

The already approved drug is usually administered as an injection every 12 weeks for patients. After the injection is received, the amount of drug in the blood is much higher than required, while after the 12 weeks are almost over, the levels fall below what is required. The goal of this new treatment is to provide comfortable daily administration.

This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.

Call us on 1800 243 733 to discuss your eligibility today!